NOTO, Davide
 Distribuzione geografica
Continente #
NA - Nord America 20.740
EU - Europa 8.080
AS - Asia 7.273
SA - Sud America 1.323
Continente sconosciuto - Info sul continente non disponibili 1.148
AF - Africa 218
OC - Oceania 26
Totale 38.808
Nazione #
US - Stati Uniti d'America 20.272
SG - Singapore 2.612
RU - Federazione Russa 2.050
CN - Cina 1.837
IT - Italia 1.784
BR - Brasile 998
FI - Finlandia 890
HK - Hong Kong 706
VN - Vietnam 649
DE - Germania 633
UA - Ucraina 553
PL - Polonia 472
GB - Regno Unito 433
FR - Francia 368
BD - Bangladesh 326
IE - Irlanda 323
JP - Giappone 264
CA - Canada 233
KR - Corea 157
IN - India 139
SE - Svezia 117
TR - Turchia 115
NL - Olanda 95
AR - Argentina 88
MX - Messico 83
AT - Austria 80
IQ - Iraq 72
BE - Belgio 67
EC - Ecuador 59
CO - Colombia 56
RO - Romania 52
ID - Indonesia 43
VE - Venezuela 42
ZA - Sudafrica 42
CI - Costa d'Avorio 39
PK - Pakistan 39
CR - Costa Rica 36
ES - Italia 33
MA - Marocco 33
JM - Giamaica 32
IR - Iran 31
MY - Malesia 30
PH - Filippine 29
UZ - Uzbekistan 29
CL - Cile 27
CH - Svizzera 24
AZ - Azerbaigian 22
JO - Giordania 20
SA - Arabia Saudita 20
AU - Australia 19
KE - Kenya 19
PY - Paraguay 19
AE - Emirati Arabi Uniti 17
HN - Honduras 17
DZ - Algeria 15
GR - Grecia 15
DO - Repubblica Dominicana 14
EG - Egitto 14
NP - Nepal 14
TT - Trinidad e Tobago 13
UY - Uruguay 13
BG - Bulgaria 12
IL - Israele 12
PE - Perù 12
PT - Portogallo 12
TH - Thailandia 12
KZ - Kazakistan 11
LT - Lituania 11
PA - Panama 10
TW - Taiwan 10
GT - Guatemala 9
SN - Senegal 9
TN - Tunisia 9
BO - Bolivia 8
NG - Nigeria 8
PS - Palestinian Territory 8
BA - Bosnia-Erzegovina 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
NI - Nicaragua 7
HU - Ungheria 6
NZ - Nuova Zelanda 6
AL - Albania 5
BH - Bahrain 5
BY - Bielorussia 5
GE - Georgia 5
HR - Croazia 5
MM - Myanmar 5
AO - Angola 4
EE - Estonia 4
EU - Europa 4
LK - Sri Lanka 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TG - Togo 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
CG - Congo 3
CY - Cipro 3
ET - Etiopia 3
Totale 37.610
Città #
Ashburn 2.380
Fairfield 2.108
Singapore 1.771
San Jose 1.407
Woodbridge 1.049
Chandler 998
Houston 979
Seattle 904
Wilmington 848
Hong Kong 680
Cambridge 677
Council Bluffs 596
Ann Arbor 524
Zgierz 399
Moscow 345
Palermo 329
Dublin 321
Dallas 305
Beijing 304
Medford 293
Jacksonville 291
New York 276
Los Angeles 263
Tokyo 244
Santa Clara 238
Altamura 212
Ho Chi Minh City 209
Des Moines 208
Princeton 183
Lauterbourg 180
Boardman 176
Frankfurt am Main 175
Nanjing 162
Hanoi 155
San Diego 152
Lawrence 151
Chicago 139
Dearborn 133
Helsinki 112
London 99
Buffalo 90
Tulsa 87
The Dalles 83
Shenyang 81
São Paulo 80
Milan 79
Hefei 76
Atlanta 68
Orem 67
Phoenix 67
Brussels 64
Toronto 64
Nanchang 61
Changsha 59
Rome 59
Ludwigshafen am Rhein 56
Jinan 55
Munich 53
Denver 52
Izmir 51
Hebei 50
Brooklyn 49
San Francisco 48
Tianjin 47
Jiaxing 46
Nuremberg 43
Seongnam 42
Warsaw 42
Montreal 41
Guangzhou 40
Shanghai 40
Abidjan 39
Venice 38
Amsterdam 36
Boston 35
Bremen 35
Columbus 35
Da Nang 34
Rio de Janeiro 34
Lappeenranta 33
Chennai 32
Manchester 31
Memphis 29
Philadelphia 29
Haiphong 28
Ningbo 28
Washington 28
Zhengzhou 28
Falls Church 27
Hangzhou 26
Norwalk 26
Vienna 26
Brasília 25
Naples 25
Paris 25
Saint Petersburg 25
Stockholm 25
Johannesburg 24
Ottawa 24
San José 24
Totale 23.669
Nome #
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults 664
A century of trends in adult human height 613
Multiple food hypersensitivity as a cause of refractory chronic constipation in adults 543
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 populationrepresentative studies with 141 million participants 439
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 309
TERAPIA CON STATINE IN PAZIENTI SICILIANI AFFETTI DA IPERLIPIDEMIA FAMILIARE COMBINATA 307
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 306
A NOVEL APOB MUTATION IDENTIFIED BY EXOME SEQUENCING COSEGREGATES WITH STEATOSIS, LIVER CANCER AND HYPOCHOLESTEROLEMIA 296
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 288
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 286
Chronic constipation and food intolerance: a model of proctitis causing constipation 286
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 284
A NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS 278
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 276
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 275
The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. 272
BETA-2-GLYCOPROTEIN I IS GROWTH REGULATED AND PLAYS A ROLE AS SURVIVAL FACTOR FOR HEPATOCYTES 270
FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease 270
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 270
Clinical symptoms in celiac patients on a gluten-free diet. 267
Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent 265
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. 265
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 261
A novel putative interactor for the low density lipoprotein receptor cytoplasmic domain 259
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 259
PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study 259
A Novel Mutation of the DHCR7 Gene in a Sicilian Compound Heterozygote with Smith-Lemli-Opitz Syndrome 257
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population. 256
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 255
Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics 250
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 249
A novel component of the metabolic syndrome : The oxidative stress 248
Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study 247
RUOLO DEL POLIMORFISMO ILE148MET DEL GENE PNPLA3 NELLA STEATOSI ASSOCIATA ALLA IPOBETALIPOPROTEINEMIA FAMILIARE 247
Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. 246
Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 245
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS 242
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: A possible role in glucocorticoid deficiency 242
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 241
REPOSITIONING OF THE GLOBAL EPICENTRE OF NON-OPTIMAL CHOLESTEROL 232
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 232
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 230
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins 227
A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia. 227
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants 227
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study 226
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. 225
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 225
The ANP Genetic Variant RS5068 is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population 223
Metabolomic analysis of plasma from Alzheimer disease patients 223
LA LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE: ANALISI DELLA CINETICA DELL’ACIDO PALMITICO MEDIANTE L’USO DI UN ISOTOPO STABILE IN UN MODELLO IN VITRO 223
Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells 222
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” 221
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants 219
Lipoprotein-associated phospholipase A2 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia 219
No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. 218
Obesity and the metabolic syndrome in a student cohort from Southern Italy 218
LIPASE MATURATION FACTOR 1 IS REQUIRED FOR ENDOTHELIAL LIPASE ACTIVITY 218
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 218
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 217
Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model 216
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 215
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 215
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 214
Trends in Adult Body-Mass Index in 200 Countries From 1975 to 2014: A Pooled Analysis of 1698 Population-Based Measurement Studies With 19·2 Million Participants 214
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 214
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 212
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 212
Role of Nutraceuticals in Hypolipidemic Therapy 211
Molecular diagnosis of hypobetalipoproteinemia: An ENID review 210
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 210
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 210
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 208
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 208
Genetic epidemiology of ARH in Sicily 206
Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension 206
COMPOUND HETEROZYGOUS FH AND FDB: IDENTIFICATION OF A SICILIAN FAMILY HARBOURING THE FDB3531 MUTATION AND THE Y398X MUTATION OF THE LDL RECEPTOR GENE. 204
PREVALENCE OF ANGPTL3 AND APOB GENE MUTATIONS IN SUBJECTS WITH COMBINED HYPOLIPIDEMIA 203
Prothrombotic gene variants as risk factors of acute myocardial infarction in young women. 203
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 203
The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction 202
Lipid Peroxidation, Nitric Oxide Metabolites, and Their Ratio in a Group of Subjects with Metabolic Syndrome 201
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 200
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 198
NEXT GENERATION SEQUENCIN: A NEW METHODOLOGICAL APPROACH FOR THE MOLECULAR DIAGNOSIS OF GENETIC DYSLIPIDEMIAS 197
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 195
FAMILIAL HYPOBETALIPOPROTEINEMIA DUE TO APOLIPOPROTEIN B GENE MUTATIONS CAUSES INTESTINAL FAT ACCUMULATION AND LIPID MALABSORPTION. 194
RT-PCR and in situ hybridization analysis of apolipoprotein H expression in rat normal tissues 194
Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia 194
LIPIDOMICS OF HUMAN SKIN FIBROBLASTS IN NEIMANN-PICK DISEASE TYPE C 193
ΒETA ARRESTIN-2: A NEW “ACTOR” IN THE LDL-R ENDOCYTOSIS? 192
Protein oxidation in a group of subjects with metabolic syndrome. 191
Clinical, molecular and functional characterization of two novel mutations associated to compound heterozygous FHBL 190
Automated untargeted stable isotope assisted lipidomics of liver cells on high glucose shows alteration of sphingolipid kinetics 190
Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. 189
DETECTION OF NEW GENES RESPONSIBLE OF FAMILIAL RECESSIVE HYPERCHOLESTEROLEMIA: PRELIMINARY DATA FROM AN EXOME SEQUENCING APPROACH 189
Anti-PCSK9 treatment: Is ultra-low LDL always good? 189
HETEROGENITY OF AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN SICILY 188
INTERACTION OF THE INTRACELLULAR DOMAIN OF THE LOW DENSITY LIPOPROTEIN (LDL) RECPTOR WITH METALLOTHIONEIN2 (MT2). 187
Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: The Ventimiglia di Sicilia project 186
Totale 24.335
Categoria #
all - tutte 127.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.630 0 0 0 52 60 86 95 125 364 319 123 406
2022/20232.947 316 608 60 327 339 437 172 189 308 27 110 54
2023/20241.348 63 184 98 171 87 319 115 39 22 36 39 175
2024/20253.537 72 236 236 250 131 165 279 276 296 384 498 714
2025/202612.650 795 441 691 966 1.280 1.814 1.765 1.266 934 1.538 567 593
2026/20273.767 738 709 2.275 45 0 0 0 0 0 0 0 0
Totale 38.808